AD-05

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAD-05
Drug Alias NameAffitope-AD05Ab-AD05
ClassificationVaccines
Mechanisms of ActionAmyloid beta-protein precursor inhibitorsImmunostimulants
TargetsAmyloid beta-protein precursor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffiris Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffiris Ag
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A